Journal Logo


  • Updated:   9/7/2022
  • Contains:  36 items
Below you can find all of HemaSphere's published content related to COVID-19.

Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy

Ntanasis-Stathopoulos, Ioannis; Karalis, Vangelis; Gavriatopoulou, Maria; More

HemaSphere. 6(8):e764, August 2022.

Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

Ntanasis-Stathopoulos, Ioannis; Karalis, Vangelis; Sklirou, Aimilia D.; More

HemaSphere. 6(7):e747, July 2022.

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma—Report From the European MCL Registry

Tilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra; More

HemaSphere. 6(5):e0711, May 2022.

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies

Petzer, Verena; Steiner, Normann; Angelova-Unterberger, Olga; More

HemaSphere. 6(3):e686, March 2022.

Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals

Terpos, Evangelos; Karalis, Vangelis; Ntanasis-Stathopoulos, Ioannis; More

HemaSphere. 6(1):e677, January 2022.

COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma

Gaitzsch, Erik; Passerini, Verena; Khatamzas, Elham; More

HemaSphere. 5(7):e603, July 2021.

Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021

Saunders, Jamie; Curto-Garcia, Natalia; Sriskandarajah, Priya; More

HemaSphere. 5(7):e609, July 2021.

COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment

Clerico, Michele; Dogliotti, Irene; Calcagno, Andrea; More

HemaSphere. 5(7):e592, July 2021.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

Regalado-Artamendi, Isabel; Jiménez-Ubieto, Ana; Hernández-Rivas, José Ángel; More

HemaSphere. 5(3):e538, March 2021.

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience

Mossuto, Sandra; Attardi, Enrico; Alesiani, Francesco; More

HemaSphere. 4(5):e483, October 2020.

COVID-19 – Impact on Childhood Haematology Patients

Wolfs, Tom F.W.; Attarbaschi, Andishe; Balduzzi, Adriana; More

HemaSphere. 4(5):e465, October 2020.

Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threatening Features Within the Early Post-engraftment Phase

Oltolini, Chiara; Guidetti, Anna; Ripa, Marco; More

HemaSphere. 4(4):e448, August 2020.

Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19

Hameister, Erik; Stolz, Sebastian M.; Fuhrer, Yvonne; More

HemaSphere. 4(4):e453, August 2020.

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Talaulikar, Dipti; Advani, Ranjana H.; Branagan, Andrew R.; More

HemaSphere. 4(4):e433, August 2020.